Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

3721 TecPort Drive, Suite 301
Harrisburg, PA 17111
Phone: 717-914-4067

MacuLogix, Inc. equips eye care professionals with the instrument, tools and education needed to effectively diagnose and treat patients with AMD. By leveraging the science of dark adaptation through its AdaptDx, MacuLogix is working to eliminate preventable blindness caused by AMD, a chronic, progressive disease that impacts over 170 million people worldwide and goes undiagnosed in 25 percent of patients. The AdaptDx dark adaptometer enables eye care professionals to detect, monitor and treat AMD three years before it can be seen clinically. MacuLogix provides in-practice training and treatment best practices to support the implementation and optimization of the AdaptDx.

Key Contact
William McPhee
Funding Events

03/11/13 $3,600,000 Series A Ben Franklin Technology Partners of Central and Northern Pennsylvania
Berwind Private Equity
Life Sciences Greenhouse of Central Pennsylvania
Roche Venture Fund
03/04/19 $38,700,000 Series D Berwind Private Equity
Fisk Ventures
Life Sciences Greenhouse of Central Pennsylvania
Roche Venture Fund
Vivo Capital

Featured Reading